269 related articles for article (PubMed ID: 36699080)
1. Drug-induced thrombotic microangiopathy: An updated review of causative drugs, pathophysiology, and management.
Mazzierli T; Allegretta F; Maffini E; Allinovi M
Front Pharmacol; 2022; 13():1088031. PubMed ID: 36699080
[TBL] [Abstract][Full Text] [Related]
2. Drug-induced thrombotic microangiopathy: Experience of the Oklahoma Registry and the BloodCenter of Wisconsin.
Reese JA; Bougie DW; Curtis BR; Terrell DR; Vesely SK; Aster RH; George JN
Am J Hematol; 2015 May; 90(5):406-10. PubMed ID: 25639727
[TBL] [Abstract][Full Text] [Related]
3. A Case Report of Quinine-Induced Thrombotic Microangiopathy Successfully Treated With Eculizumab.
Ng JY; Lenton D; Kerridge I; Wong C
J Investig Med High Impact Case Rep; 2024; 12():23247096241235617. PubMed ID: 38477293
[TBL] [Abstract][Full Text] [Related]
4. Making the Correct Diagnosis in Thrombotic Microangiopathy: A Narrative Review.
McFarlane PA; Bitzan M; Broome C; Baran D; Garland J; Girard LP; Grewal K; Lapeyraque AL; Patriquin CJ; Pavenski K; Licht C
Can J Kidney Health Dis; 2021; 8():20543581211008707. PubMed ID: 33996107
[TBL] [Abstract][Full Text] [Related]
5. Unique Presentation of Bortezomib-Associated Thrombotic Microangiopathy Responsive to Therapeutic Plasma Exchange and Eculizumab Therapy.
Sterner RC; Rose WN
Hematol Rep; 2022 Apr; 14(2):119-125. PubMed ID: 35466182
[TBL] [Abstract][Full Text] [Related]
6. Renal-Limited Thrombotic Microangiopathy in a Patient Who Received Gemcitabine, Ramucirumab, and Pembrolizumab: A Case Report and Literature Review.
Patel SS; Shan HY
Cureus; 2024 Feb; 16(2):e53669. PubMed ID: 38455838
[TBL] [Abstract][Full Text] [Related]
7. Complement in Secondary Thrombotic Microangiopathy.
Palma LMP; Sridharan M; Sethi S
Kidney Int Rep; 2021 Jan; 6(1):11-23. PubMed ID: 33102952
[TBL] [Abstract][Full Text] [Related]
8. Thrombotic Microangiopathy Syndromes-Common Ground and Distinct Frontiers.
Hanna RM; Henriksen K; Kalantar-Zadeh K; Ferrey A; Burwick R; Jhaveri KD
Adv Chronic Kidney Dis; 2022 Mar; 29(2):149-160.e1. PubMed ID: 35817522
[TBL] [Abstract][Full Text] [Related]
9. Complement in Thrombotic Microangiopathies: Unraveling Ariadne's Thread Into the Labyrinth of Complement Therapeutics.
Gavriilaki E; Anagnostopoulos A; Mastellos DC
Front Immunol; 2019; 10():337. PubMed ID: 30891033
[TBL] [Abstract][Full Text] [Related]
10. A case off TTP temporally associated with cocaine use: Implications for treatment of suspected DITMA.
Regner SR; Lerfald N
J Clin Apher; 2019 Aug; 34(4):510-512. PubMed ID: 30776151
[TBL] [Abstract][Full Text] [Related]
11. Prospective registry of adult patients receiving therapeutic plasma exchange with a presumptive diagnosis of thrombotic microangiopathy (TMA): The Turkish hematology research and education group (ThREG)-TMA02 study.
Akpınar S; Tekgunduz E; Erkurt MA; Esen R; Yılmaz M; Karakus V; Vural F; Gediz F; Aydogdu I; Kaynar L; Korkmaz S; Goker H; Kelkitli E; Ayyıldız O; Demirkan F
Transfus Apher Sci; 2021 Nov; ():103312. PubMed ID: 34799244
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy-Associated Thrombotic Microangiopathy.
Aklilu AM; Shirali AC
Kidney360; 2023 Mar; 4(3):409-422. PubMed ID: 36706238
[TBL] [Abstract][Full Text] [Related]
13. Patients with hypertension-associated thrombotic microangiopathy may present with complement abnormalities.
Timmermans SAMEG; Abdul-Hamid MA; Vanderlocht J; Damoiseaux JGMC; Reutelingsperger CP; van Paassen P;
Kidney Int; 2017 Jun; 91(6):1420-1425. PubMed ID: 28187980
[TBL] [Abstract][Full Text] [Related]
14. Plasma exchange in thrombotic microangiopathies (TMAs) other than thrombotic thrombocytopenic purpura (TTP).
Winters JL
Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):632-638. PubMed ID: 29222314
[TBL] [Abstract][Full Text] [Related]
15. The Use of Eculizumab in Tacrolimus-Induced Thrombotic Microangiopathy.
Gabr JB; Bilal H; Mirchia K; Perl A
J Investig Med High Impact Case Rep; 2020; 8():2324709620947266. PubMed ID: 32757799
[TBL] [Abstract][Full Text] [Related]
16. A new pathological perspective on thrombotic microangiopathy.
Kim YJ
Kidney Res Clin Pract; 2022 Sep; 41(5):524-532. PubMed ID: 35791743
[TBL] [Abstract][Full Text] [Related]
17. [Thrombotic microangiopathy].
Schmidt T; Huber TB
Med Klin Intensivmed Notfmed; 2023 Feb; 118(1):14-20. PubMed ID: 36633606
[TBL] [Abstract][Full Text] [Related]
18. An updated classification of thrombotic microangiopathies and treatment of complement gene variant-mediated thrombotic microangiopathy.
Aigner C; Schmidt A; Gaggl M; Sunder-Plassmann G
Clin Kidney J; 2019 Jun; 12(3):333-337. PubMed ID: 31198225
[TBL] [Abstract][Full Text] [Related]
19. Thrombotic microangiopathies: thrombotic thrombocytopenic purpura / hemolytic uremic syndrome.
Polito MG; Kirsztajn GM
J Bras Nefrol; 2010; 32(3):303-15. PubMed ID: 21103695
[TBL] [Abstract][Full Text] [Related]
20. Complement activation in diseases presenting with thrombotic microangiopathy.
Meri S
Eur J Intern Med; 2013 Sep; 24(6):496-502. PubMed ID: 23743117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
